	Complete Response in Metastatic Rectal Cancer with Hepatic and Pulmonary Metastases Treated with Second-Line FOLFIRI plus Ramucirumab: A Case Report. Case Rep Oncol Hasegawa M, Okayama H, Kitabori Y, Yamauchi N, Nakajima T, Matsumoto S, Sato N, Saito M, Kono K. PMID: 42312106 [PubMed]
	A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma. MedComm (2020) Hu M, Liu S, Han Y, Wang F, Liu Y, Lu B, Li H, Gao Y, Wang Y, Yang W, Shi K, Xiao B, Wang Q, Du J, Lin H, Li X, Wang C, Zhang T. PMID: 42311860 [PubMed]
	Risk prediction models for postoperative atrial fibrillation in patients with lung cancer: a systematic review and meta-analysis. Front Cardiovasc Med Yang F, Sun T, Shang Y, Chen Y, Wu J, Shang X. PMID: 42311770 [PubMed]
	Current status and trends of immune-related adverse events in lung cancer treated with immune checkpoint inhibitors: a bibliometric analysis of the past decade (2016-2025). Front Immunol Guo B, Zhang G, Sang S, Ma X, Qi H. PMID: 42311664 [PubMed - indexed for MEDLINE]
	Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imaging. Front Immunol Qie S, Shi Y, Li J, Jia S, Yin X. PMID: 42311663 [PubMed - indexed for MEDLINE]
	Multimodal diagnostic network integrating infrared and mass spectra for lung cancer. Biomed Opt Express Huang L, Zhao X, Tian Y, Shao J, Liu G, Wu C. PMID: 42311313 [PubMed]
	Radiomics to understand pre-treatment tumor biology for resectable non-small cell lung cancer. Front Oncol Zollinger B, Pham D, Suzuki K. PMID: 42311254 [PubMed]
	Associations between systemic immune-inflammation index and immune-related hypothyroidism in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a retrospective study. Front Oncol Dai W, Li Q, Wang M, Wang C, Cao H. PMID: 42311250 [PubMed]
	Evaluation of zongertinib for the treatment of metastatic non-squamous non-small cell lung cancer with HER2 TKD activating mutation. Expert Opin Pharmacother Chen M, Gandhib J, Wu S, Cheng H. PMID: 42311064 [PubMed - as supplied by publisher]
	Lung cancer multimodal auxiliary diagnosis based on entropy weight decision fusion. Biomed Eng Online Zhang H, Tang Y, Li P, Fan W, Chen X. PMID: 42310728 [PubMed - as supplied by publisher]
	Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-small-cell Lung Cancer. Ann Surg Oncol Tane S, Nomura K, Watanabe T, Takamori S, Ohara S, Oiki H, Katsumata S, Takamori S, Nakatsuka M, Tenpaku H, Nakamura R, Notsuda H, Namba K, Minegishi K, Kitamura Y, Abe M, Takegahara K, Konno H, Mizuno K, Toyoda T, Muto S, Toda M, Endo M, Maniwa Y, Soh J, Ohde Y. PMID: 42310265 [PubMed - as supplied by publisher]
	Deep integration of clinical metadata with [(18)F]FDG PET/CT imaging for histological subtyping in non-small cell lung cancer: a multi-center study. Eur J Nucl Med Mol Imaging Zhang J, Zhang X, Wang J, Hao H, Hu D, Hu K, Li X, Li Y, Liu G, Tian R, Wu W, Ma X, Huang Y, Jin C, Zhong Y, Tian M, Zhang H. PMID: 42310216 [PubMed - as supplied by publisher]
	Establishment and validation of an ADP-ribosylation-related gene signature for prognostic prediction in lung adenocarcinoma. Discov Oncol Luo X. PMID: 42310154 [PubMed - as supplied by publisher]
	Repeatability of AI-quantified incidental findings on lung cancer screening CT scans in the NELSON trial. Eur Radiol Bunk S, Bruins Slot T, Bennink E, Sidorenkov G, van der Velden N, Schurink N, Lades F, Sebald M, Heuvelmans MA, Gietema HA, Aerts JG, de Bock GH, Schaefer-Prokop C, de Jong PA, Vliegenthart R, Mohamed Hoesein FAA, NELSON-POP consortium. PMID: 42310036 [PubMed - as supplied by publisher]
	Association Between Osimertinib Dose Reduction and Treatment Outcomes in First-Line EGFR-Mutated Advanced NSCLC: The Impact of Post-Progression Management. Thorac Cancer Oi I, Fujita K, Imakita T, Tukino M, Noguchi T, Okada Y, Yoshimura S, Fujimoto N, Toyama S, Watanabe A, Ito T, Kaku R, Kanai O, Ohuchi M, Tanizawa K, Sawai S, Mio T. PMID: 42309786 [PubMed - indexed for MEDLINE]
	Effectiveness of preoperative pulmonary rehabilitation in patients with lung cancer combined with moderate to severe COPD: study protocol for a randomized controlled trial. Respir Med Yang JY, Lv L, Ni J. PMID: 42309231 [PubMed - as supplied by publisher]
	Letter to the editor regarding: "Glycosylation-associated plasma SNORD99 as a novel diagnostic biomarker for early-stage lung adenocarcinoma". Clinica Chimica acta 580(2026) 120722. Clin Chim Acta Gao P, Liu F, Liu M, Yu J. PMID: 42309214 [PubMed - as supplied by publisher]
	A novel C17-sesquiterpene alkaloid derived from Dendrobium huoshanense: in vitro evaluation of its anti-lung cancer activity and molecular dynamics simulation study. Nat Prod Res Chen J, Li XM, Sun YP, Dai YF, Li SH, Chen NF, Chen ND. PMID: 42308126 [PubMed - as supplied by publisher]
	Artificial Intelligence Is Not a Panacea: LungIMPACT Trial Shows Prioritization Cannot Overcome Systemic Delays in Lung Cancer Diagnosis. AJR Am J Roentgenol Brooks MA. PMID: 42308095 [PubMed - as supplied by publisher]
	Attenuation- and Entropy-Based Habitat Imaging for High-Risk Features in Lung Adenocarcinoma Presenting as a Part-Solid Nodule on CT: A Multicenter Study. AJR Am J Roentgenol Li Y, Li X, Long Y, Zheng Y, Liang J, Lin W, Yao L, Qing H, Zhou P, Liu J. PMID: 42308091 [PubMed - as supplied by publisher]

Articles 1 - 20 / 160575

Page 1 of 8029



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy